Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Menopause Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The menopause market size has experienced robust growth in recent years. It is projected to expand from $18.78 billion in 2025 to $19.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. This growth in the historical period is attributable to an aging female population, increased life expectancy among women, the widespread use of hormone replacement therapy, rising awareness of menopausal symptoms, and the expansion of women’s healthcare services.
The menopause market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $26.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the forecast period include an increasing need for safer long-term therapeutic options, the proliferation of digital health platforms centered on menopause, a heightened emphasis on women’s preventive health, broader accessibility to online pharmacies, and a wider embrace of alternative and lifestyle-oriented treatments. Key trends anticipated during this period encompass a rise in the use of non-hormonal menopause therapies, enhanced awareness and proactive approaches to menopause management, a growing inclination towards dietary supplements and natural remedies, the expansion of individualized menopause care initiatives, and an elevated demand for solutions targeting specific symptoms.
Get A Free Sample Report With In-Depth Market Insights:
Menopause Market Expansion Drivers: What’s Shaping Future Growth?
The anticipated growth of the menopause market is significantly influenced by the rise in evolving lifestyles. These changing lifestyles refer to shifts in how individuals live and make choices that impact their health and well-being. During this natural biological phase, adapting one’s lifestyle can assist in managing menopausal symptoms and enhancing general health. Menopause can prompt various adjustments to lifestyle choices, including adopting a nutritious diet, engaging in regular physical activity, ensuring sufficient sleep, abstaining from smoking and excessive alcohol consumption, and participating in calming hobbies. For instance, in November 2023, the Global Wellness Institution, a US-based organization, released information stating that in 2022, the wellness economy represented 5.6% of global economic output and is projected to expand to $8.5 trillion by 2027, with an average annual growth rate of 8.6%. Consequently, the increasing trend of changing lifestyles is driving the expansion of the menopause market.
Menopause Market Segment Analysis Spotlighting Growth Areas
The menopause market covered in this report is segmented –
1) By Treatment: Dietary Supplements, Over-The-Counter (OTC) Pharma Products
2) By Route Of Administration: Topical, Oral, Injectables
3) By Distribution Channel: Hospital, Retail, Online Pharmacies
4) By End User: Hospital, Diagnostic Centers, Specialty Clinics, Other End Users
Subsegments:
1) By Dietary Supplements: Herbal Supplements, Vitamins And Minerals, Phytoestrogens, Omega-3 Fatty Acids, Probiotics
2) By Over-The-Counter (OTC) Pharma Products: Hormone Replacement Therapy (HRT), Non-Hormonal OTC Products, Antidepressants For Mood Swings, Sleep Aids, Pain Relievers
Menopause Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies within the menopause market are concentrating on creating cutting-edge treatments, such as dual neurokinin 1/neurokinin 3 (NK1/NK3) receptor antagonists, to provide non-hormonal options for vasomotor symptoms (hot flashes and night sweats) and enhance the quality of life for women experiencing menopause. These dual neurokinin 1/neurokinin 3 receptor antagonists are defined as oral medications that concurrently obstruct both NK1 and NK3 receptors in the hypothalamus, consequently influencing the neuropeptide pathways involved in thermoregulation and sweat responses, leading to a decrease in the incidence and intensity of hot flashes and related sleep disruptions. A notable example is Bayer AG, a Germany-based pharmaceutical company, which secured approval from the U.S. Food and Drug Administration (FDA) in October 2025 for Lynkuet (elinzanetant) 60 mg capsules, recognized as the world’s first dual-NK1/NK3 receptor antagonist specifically sanctioned for managing moderate to severe hot flashes stemming from menopause. Lynkuet provides once-daily bedtime administration, substantial reductions in both the frequency and severity of hot flashes, as evidenced across three Phase III trials (OASIS 1/2/3), alongside a non-hormonal mode of action that expands therapeutic possibilities for women unable to use hormone therapy.
Menopause Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the menopause market are Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A, Abbott Laboratories Ltd., GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., Serenity Pharmaceuticals LLC
View The Full Menopause Market Report:
Menopause Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the menopause market in 2025. The regions covered in the menopause market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
